Researchers at University College London have introduced a new diagnostic test, Decipher, which aims to identify men with high-risk prostate cancer who may benefit from aggressive treatment. The study analyzed data from over 27,000 patients and highlighted that higher Decipher scores are associated with a greater likelihood of cancer spread. The findings were presented at the ESMO Congress 2026, and while the test shows promise, further validation is necessary before it can be routinely implemented in treatment decisions.
Key facts
- The Decipher test analyzes tissue to guide treatment decisions for prostate cancer.
- Findings were presented at the ESMO Congress 2026 in Madrid from October 23 to 27.
- Higher Decipher scores indicate a higher risk of cancer spread.
- Prostate cancer is the second-leading cause of cancer death in men in the US.
- About one in eight American men will be diagnosed with prostate cancer.
A short AI summary in our own words. The reporting belongs to Fox News — Latest; we don't reproduce it.